Skip to main content
UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center

News releases

October 2017arrow

Moonshot grant advances immune therapy for dogs - and one day people - with cancer

October 20, 2017

UC Davis has received its first National Cancer Institute (NCI) Moonshot grant  ̶  $2.5 million over five years  ̶  to explore immunotherapy treatments for dogs who develop melanoma and osteosarcoma and that may one day benefit humans, as well.

Cancer Center hosts lung cancer research conference

October 19, 2017

Members of the UC Davis Comprehensive Cancer Center lung cancer treatment team will present at WCLC 2017, a one-day conference on Saturday, Nov. 11, from 7 a.m. to 4 p.m. in San Francisco. Presenters will share the latest lung cancer and other thoracic malignancy advances highlighted at the recent 18th Annual World Conference on Lung Cancer in Japan.

"Smart" immune cells: Emerging cancer therapy research at UC Davis receives a boost with NIH award

October 6, 2017

Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics, has received a $1.5 million award from the National Institutes of Health to advance the development of “smart” immune cells for therapies to treat cancer and other diseases. The five-year NIH Director’s New Innovator Award aims to provide new insight into how to engineer immune cells to control their recruitment and response to tumors.

2017-2018 Human Genomics Seminar Series starts Oct. 4

October 3, 2017

UC Davis Children's Hospital, UC Davis Comprehensive Cancer Center and the UC Davis Genome Center are hosting the 2017-2018 Human Genomics Seminar Series, a monthly series focusing on genomic medicine topics, led by UC Davis faculty. Seminars will be held the first Wednesday of every month at noon at the Center for Health and Technology, room 1341.

September 2017arrow

UC Davis receives $8 million to expand access to stem cell clinical trials

September 28, 2017

The California Institute for Regenerative Medicine today awarded a nearly $8 million grant to University of California, Davis, stem cell researchers to launch a special clinical trials program in Sacramento to accelerate the therapeutic development and delivery of stem cell therapies in human patients.

$3.3 million grant funds early detection of pancreatic cancer

September 27, 2017

UC Davis researchers, led by Julie Sutcliffe, have received a $3.3 million grant from the National Institutes of Health to advance efforts to diagnose pancreatic cancer before it spreads.

August 2017arrow

Knoepfler awarded second Alex's Lemonade Stand research grant

August 30, 2017

UC Davis stem cell scientist Paul Knoepfler has been awarded a second $250,000 grant for glioma research from an organization begun 15 years ago by a 5-year-old girl with a deadly form of childhood cancer.

Before sarcoma surgery - radiation

August 18, 2017

UC Davis researchers have shown that radiation therapy before surgery improves overall survival for patients with soft tissue sarcomas. This pre-surgical, or neoadjuvant, radiotherapy allows surgeons to get better margins around tumors and remove even microscopic cancer tissue more often. The study was published recently  in the Annals of Surgical Oncology.

One of America's top hospitals

August 8, 2017

U.S. News & World Report, which annually recognizes hospitals that excel in treating patients with serious and challenging injuries and illnesses, has again ranked UC Davis Medical Center as one of the nation's best hospitals.

Leader in cross-cultural care heads general medicine at UC Davis Health

August 1, 2017

Shin-Ping Tu, a national expert on improving health care delivery and cross-cultural medical care, has become chief of the Division of General Medicine at UC Davis Health. She leads a team of nearly 40 physicians who provide comprehensive treatment to adults and research innovative ways to advance patient care, train physicians and improve health policy.

July 2017arrow

Massive study launched to test personalized approach to breast cancer screening

July 26, 2017

Sorting out when or whether to get mammograms can be perplexing for any woman, and a health provider’s advice may not settle the matter. That’s because even experts disagree about when screening mammography is appropriate and for whom.

June 2017arrow

UC Davis Health hosts migrant student workshop

June 20, 2017

UC Davis Health welcomes 145 migrant high school students Sunday, June 25 for a day of tours, talks and opportunities to learn more about medical science from students, fellows and faculty.

How treating a dog's tumors may help in the fight against human cancer

June 6, 2017

With its internationally renowned school of veterinary medicine and its NCI-designated comprehensive cancer center, UC Davis is uniquely positioned to harness the power of each to tackle one of life’s greatest challenges: cancer.

Gandara named "Giant of Cancer Care"

June 2, 2017

David R. Gandara, professor and director of thoracic oncology at UC Davis Comprehensive Cancer Center, has been named a “Giant of Cancer Care” in lung cancer by OncLive in recognition of his work to advance the field of oncology through his contributions in research and clinical practice.

May 2017arrow

UC Davis signs agreement to license novel CT scanning technology

May 24, 2017

UC Davis has signed a licensing agreement providing Isotropic Imaging Corporation the rights to commercialize a novel computed tomography (CT) scanner that has the potential to improve breast cancer detection and positively impact women’s health.

In Memoriam: Robert E. Chason, former UC Davis Medical Center CEO

May 10, 2017

Former UC Davis Medical Center Chief Executive Officer Robert E. Chason passed away on May 8, 2017, following a brief illness. He was 73.

April 2017arrow

UC Davis cancer researcher receives Kimmel Scholar Award

April 25, 2017

Sean Collins, assistant professor of microbiology and molecular genetics in the UC Davis College of Biological Sciences, has received a Kimmel Scholar Award from the Sidney Kimmel Foundation.

Early cancer deaths linked to being single, living in a poor neighborhood

April 25, 2017

Patients in California hospitals were more likely to die within 60 days of being diagnosed with acute myeloid leukemia – a cancer of the blood and bone marrow – if they were unmarried, lived in a less-affluent neighborhood or lacked health insurance. The UC Davis study also found that patients treated at a National Cancer Institute (NCI)-designated cancer center were more likely to survive.

Second cancers deadlier in young patients

April 20, 2017

Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found.

March 2017arrow

Hitting cancer with high-intensity ultrasound and immunotherapy

March 23, 2017

In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.

UC Davis music, pet and cuddle therapy programs featured in new KVIE documentary

March 21, 2017

Three UC Davis programs are featured in a new documentary produced by KVIE that explores non-pharmacological approaches to helping people heal.

February 2017arrow

Research linking obesity to immune function and disease gets funding boost

February 23, 2017

Researchers at UC Davis have received $3.2 million in federal funds to further investigate how obesity and inflammation affect the body’s immune system in fighting cancer.

UC Davis study finds mold, bacterial contaminants in medical marijuana samples

February 7, 2017

UC Davis physician researchers have found that medical marijuana contains multiple bacterial and fungal pathogens that may cause serious and even fatal infections. They warn that smoking, vaping or inhaling aerosolized marijuana could pose a grave risk to patients, especially those with leukemia, lymphoma, AIDS or conditions requiring immune-suppressing therapies.

January 2017arrow

UC Davis Cancer Care Network welcomes two new sites

January 26, 2017

The UC Davis Health Cancer Care Network of community oncology programs has expanded to include Barton Health in Lake Tahoe and Ridgecrest Regional Hospital in the southeastern Sierra.

Faulty DNA error correction genes set stage for familial gastric cancer

January 19, 2017

A large team of researchers from UC Davis and several European and Latin American institutions have identified genetic variations that contribute to familial gastric cancer. These inherited mutations, which affect the PALB2, BRCA1 and RAD51C genes and have been implicated in other cancer types, impair a critical DNA repair mechanism called homologous recombination. These findings could improve preventive care, as well as provide targets for new therapies. The study was published last month in the journal Gastroenterology.

Many late-stage lung cancer patients do not get treatment

January 18, 2017

A national study by researchers at UC Davis Comprehensive Cancer Center has found that a significant number of lung cancer patients are not receiving treatment. Based on data between 1998 and 2012 from the National Cancer Database, 21 percent of patients (190,539) with non-small cell lung cancer (NSCLC) received no specific cancer treatment, such as chemotherapy, radiotherapy or surgery. Many of the untreated patients were women, elderly, minorities, low income and uninsured.

World's first total-body PET scanner takes big step forward

January 17, 2017

The UC Davis-based EXPLORER consortium, which aims to build a revolutionary total-body PET (positron emission tomography) scanner, has announced the selection of two industry partners to help build the prototype device. They are United Imaging Healthcare America, a North American subsidiary of Shanghai United Imaging Healthcare, and SensL Technologies of Cork, Ireland.

UC Davis and nation's cancer centers jointly endorse updated HPV vaccine recommendations

January 11, 2017

Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), UC Davis Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the U.S. Centers for Disease Control and Prevention (CDC).

UC Davis Health welcomes Beijing medical equipment company

January 9, 2017

UC Davis Health has entered into an agreement with Top Grade Health Care to establish a translational research and development center to advance the treatment of patients with cancer.

December 2016arrow

Immunotherapy improves survival in late-stage lung cancer patients

December 12, 2016

A large trial by UC Davis professor David Gandara has found that the immunotherapy atezolizumab was superior to chemotherapy for patients with advanced non-small-cell lung cancer.

November 2016arrow

Kindness, compassion key to cancer center pharmacy program

November 16, 2016

Jacquelyn Conway, a mother who enjoys taking long walks and cooking organic meals, was told she had invasive breast cancer In August 2012. That began an arduous series of cancer treatments starting with chemotherapy – and a determined approach to survival.

Cancer research pioneer to speak on therapy advances

November 15, 2016

Alan Ashworth, renowned basic cancer scientist and president of the UCSF Helen Diller Comprehensive Cancer Center, will present a talk on synthetic lethal approaches to cancer therapy Nov. 30 at UC Davis.

Breast cancer patients have new surgery option with radioactive seed

November 3, 2016

UC Davis Comprehensive Cancer Center now offers a new technique for breast cancer patients undergoing surgery to remove breast cancer that may improve cosmetic outcomes and the patient’s surgery experience.